Skip to main content
. 2022 Sep 27;9:1012220. doi: 10.3389/fcvm.2022.1012220

Figure 1.

Figure 1

Study design and occurrence of new-onset cardiac arrhythmias. AF, atrial fibrillation; AMI, acute myocardial infarction; NOCAs, new-onset cardiac arrhythmias; T2DM, type 2 diabetes mellitus; SGLT2-i, Sodium-glucose co-transporter 2 inhibitors; VF, Ventricular Fibrillation; VT, Ventricular Tachycardia.